IMUX
Immunic Inc
NASDAQ: IMUX · HEALTHCARE · BIOTECHNOLOGY
$10.03
-6.70% today
Updated 2026-04-29
Market cap
$135.94M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.20
Dividend yield
—
52W range
$5 – $15
Volume
2.8M
Immunic Inc (IMUX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-7.83M | $-9.24M | $-28.65M | $-40.83M | $-49.95M | $-35.77M | $-40.40M | $-43.16M | $-28.55M | $-46.12M | $-83.23M | $-65.14M | $-70.83M | $-84.77M | $-85.81M |
| Capital expenditures | $18000.00 | $261000.00 | $1.48M | $1.41M | $2.34M | $556000.00 | $685000.00 | $597000.00 | $55000.00 | $146000.00 | $67000.00 | $112000.00 | $334000.00 | $264000.00 | $161000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $36000.00 | $144000.00 | $948000.00 | $2.51M | $4.03M | $4.68M | $5.48M | $3.74M | $6.51M | $2.75M | $5.95M | $7.93M | $7.10M | $8.53M | $8.86M |
| Free cash flow | $-7.85M | $-9.51M | $-30.13M | $-42.23M | $-52.29M | $-36.33M | $-41.08M | $-43.76M | $-28.60M | $-46.27M | $-83.30M | $-65.26M | $-71.16M | $-85.03M | $-85.97M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $4.74M | — | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $64.05M | $-18.82M | $-23.43M | $-3.09M | $-43.58M | $16.89M | $98.16M | $-40.46M | $20.88M | — | — | — |